Company intelligence / Profile preview
Claritas Pharmaceuticals
San Rafael, California, United Statesclaritasrx.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Claritas is advancing R-107, a nitric oxide-releasing small molecule, for viral infections including vaccine-resistant COVID-19 strains and pulmonary diseases such as PAH and ARDS. R-107 has completed preclinical studies with Phase 1 trials approved in Australia; a Phase 2a study in PAH is planned. The company also holds an option to license BZ371B for ARDS. CLA-1816 is being developed for non-opioid pain relief[3][4][5][6].
- Therapeutic areas
- PulmonologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Biozeus (option/license agreement for BZ371B)[4]CMAX Clinical Research/Australia for clinical trial execution [8]BARDA/U.S. Department of Health & Human Services funding support [6]
Beyond the preview
Go deeper on Claritas Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Claritas Pharmaceuticals.